50dbf19a16d0f3e765286821932d4181.jpg

Dyndrite to power HARP, CBAM and new Meteoryte software 3D Printer Hardware

by Technologies

Dyndrite, the company that developed an accelerated computation engine to control to handle large digital manufacturing files, has extended and signed new partnerships with key AM industry pioneers such as Azul 3D, Impossible Objects and Meteor Inkjet’s new Meteoryte software. It should be noted that these companies have developed, or contributed to develop, some of the most complex and unique AM processes such as HARP, CBAM and material jetting in general. The GPU-accelerated Dyndrite software will help these companies with scalability, automation and overall improved performance to solve the toughest geometry and compute problems.

554a0d8581716f391d56b3bc89466a86.jpg

Markforged CEO Shai Terem: “Real growth is coming to AM” Decision Makers

by Technologies

After going public and trading on NYSE since July 2021, Markforged has been releasing detailed data on its performance. For over a decade, all 3D printing stocks have suffered from long periods of decreasing value interrupted by short bursts of very rapid growth. Markforged’s stock has been no different; and yet the company’s growth has been solid, regular and organic, with a “strong balance sheet and a track record of execution to our industry”, as Markforged CEO Shai Terem put it during the latest analyst call on Q1 2022 results when the company reported revenues of $21.9 million and 8.6% YoY growth. 3dpbm had the opportunity to speak with Mr. Terem about Markforged’s latest results, ongoing growth strategy and medium to long-term goals.

Humabiologics partners with Fisher Scientific Bioprinting

Humabiologics Partners with Fisher Scientific Bioprinting

by Medical

Humabiologics, an industry leader in providing human-derived biomaterials for regenerative medicine, founded by scientists and tissue industry experts to address the gap between the gift of donated human tissues and researchers, and Fisher Scientific, a global leader in life sciences, are partnering to serve researchers in academia and industry who are working on regenerative medicine research.